A Phase 3 Multicenter Study of the Safety and Efficacy of Adalimumab in Subjects with Moderate to Severe Hidradenitis Suppurativa (Initiation trial for 1 year) (2013-2014)
Experts
Professor
Peter Soyer
Affiliate of Queensland Digital Health Centre
Queensland Digital Health Centre
Faculty of Health, Medicine and Behavioural Sciences
Professorial Research Fellow
Frazer Institute
Faculty of Health, Medicine and Behavioural Sciences
